60.58
+0.10%
Close of 9 Nov 2026, in EUR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in EUR, from our data supplier.
Revenue
€6.52bn
FY2016FY2025
Net income
€1.34bn
FY2016FY2025
Free cash flow
€2.09bn
FY2016FY2025
Shareholders' equity
€4.85bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | €6.52bn | €6.14bn | €5.44bn | €4.49bn | €2.67bn | €2.17bn | €5.57bn | €4.94bn | €4.85bn | €4.47bn |
| Research and development | — | — | €1.12bn | €988.4m | €377.9m | — | — | — | €299.0m | €291.9m |
| Operating income | €1.81bn | €1.63bn | €1.41bn | €962.7m | −€28.2m | −€793.0m | €1.48bn | €1.39bn | €1.32bn | €1.21bn |
| Net income | €1.34bn | €1.25bn | €1.12bn | €664.4m | −€142.4m | −€617.6m | €1.11bn | €1.00bn | €1.00bn | €825.5m |
| Diluted earnings per share | 3.08 | 2.77 | 2.44 | 1.43 | -0.32 | -1.37 | 2.58 | 2.33 | 2.29 | 1.89 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | €11.47bn | €11.78bn | €10.80bn | €11.71bn | €11.18bn | €11.70bn | €10.40bn | €10.13bn | €7.88bn | €7.77bn |
| Cash and short-term investments | €986.8m | €1.13bn | €1.06bn | €1.99bn | €1.82bn | €2.48bn | €575.3m | €572.6m | €592.1m | €471.7m |
| Total liabilities | €6.62bn | €6.72bn | €6.31bn | €7.13bn | €7.44bn | €7.94bn | €6.60bn | €6.94bn | €5.23bn | €5.01bn |
| Debt | €3.13bn | €3.35bn | €3.28bn | €4.38bn | €4.95bn | €5.64bn | €3.57bn | €3.88bn | €2.15bn | €2.39bn |
| Shareholders' equity | €4.85bn | €5.06bn | €4.48bn | €4.58bn | €3.75bn | €3.74bn | €3.78bn | €3.18bn | €2.64bn | €2.74bn |
| Shares outstanding | 434m | 452m | 459m | 465m | 450m | 451m | 431m | 431m | 438m | 437m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | €2.15bn | €2.15bn | €1.79bn | €1.44bn | €636.3m | €33.0m | €1.80bn | €1.73bn | €1.56bn | €1.49bn |
| Capital spending | −€60.4m | −€788.1m | −€600.5m | −€566.7m | −€460.2m | −€501.5m | −€736.1m | −€718.2m | −€612.1m | −€595.1m |
| Free cash flow | €2.09bn | €1.36bn | €1.19bn | €874.1m | €176.1m | −€468.5m | €1.07bn | €1.01bn | €944.9m | €897.9m |
| Dividends paid | −€615.1m | −€541.9m | −€332.5m | — | — | −€241.4m | −€506.2m | −€494.3m | −€411.3m | −€338.5m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | €1.65bn | €1.68bn | €1.62bn | €1.64bn | €1.63bn | €1.63bn | €1.54bn | €1.55bn |
| Operating income | €480.1m | €474.9m | €338.9m | €481.5m | €476.3m | €461.8m | €320.1m | €443.7m |
| Net income | €343.7m | €357.0m | €247.5m | €360.8m | €372.1m | €355.3m | €266.5m | €342.0m |
| Diluted earnings per share | 0.80 | 0.83 | 0.57 | 0.83 | 0.86 | 0.82 | 0.59 | 0.76 |
| Cash from operations | €394.0m | €449.0m | €587.0m | €713.0m | €400.0m | €484.0m | €1.17bn | €444.0m |
| Capital spending | −€151.0m | −€11.0m | −€18.0m | −€213.0m | −€185.0m | −€207.0m | −€453.0m | −€203.0m |
| Free cash flow | €243.0m | €438.0m | €569.0m | €500.0m | €215.0m | €277.0m | €717.0m | €241.0m |
| Total assets | €11.76bn | €11.43bn | €11.47bn | €11.58bn | €11.80bn | €12.20bn | €11.78bn | €11.52bn |
| Cash and short-term investments | €976.0m | €677.2m | €975.6m | €968.2m | €1.27bn | €1.49bn | €1.13bn | €1.06bn |
| Debt | €3.51bn | €813.1m | €3.09bn | €772.8m | €3.04bn | €463.5m | €3.25bn | €1.12bn |
| Shareholders' equity | €4.57bn | €4.80bn | €4.85bn | €5.07bn | €5.30bn | €5.50bn | €5.06bn | €4.78bn |
Financial ratios
Data as of 27 Sept 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|
| Operating margin | 27.8% | 26.5% | 26.0% | 21.5% | -1.1% | -36.9% | — | — |
| Net margin | 20.5% | 20.4% | 20.5% | 14.8% | -5.3% | -28.8% | — | — |
| Return on equity | 27.5% | 24.7% | 24.9% | 14.5% | -3.8% | -16.7% | — | — |
| Return on assets | 11.6% | 10.6% | 10.4% | 5.7% | -1.3% | -5.3% | — | — |
| Free cash flow yield | 9.5% | 12.1% | 9.8% | 8.1% | 4.6% | 2.2% | — | — |
| Revenue growth | 6.1% | 12.9% | 21.3% | 68.0% | 22.8% | -61.0% | — | — |
| Earnings growth | 6.6% | 12.1% | 68.2% | -566.6% | -77.2% | -156.2% | — | — |
| Current ratio | 0.82x | 0.85x | 0.96x | 1.03x | 1.32x | 1.28x | — | — |
| Debt to equity | 0.65x | 0.64x | 0.70x | 0.92x | 1.28x | 1.46x | — | — |
| Equity ratio | 42.3% | 43.0% | 41.5% | 39.1% | 33.5% | 32.0% | — | — |
| Interest coverage | 23.82x | 14.99x | 15.69x | 9.89x | -0.28x | -9.85x | — | — |
| R&D as a share of sales | — | — | 20.5% | 22.0% | 14.2% | 18.8% | 6.2% | 6.5% |
| Buybacks as a share of market value | 4.0% | 1.4% | 1.4% | -3.4% | 0.1% | -4.5% | — | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 13.3% | 24.6% | 5.2% |
| Operating income | 23.4% | — | 5.6% |
| Net income | 26.2% | — | 6.9% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | 27.2% | 25.7% | 18.2% | 22.4% |
| Net margin | 20.4% | 19.4% | 13.2% | 16.1% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 20.4 | 24.6 | 26.6 | 34.0 | -188.4 | -43.5 | 28.2 | 26.1 | 26.2 | 22.9 |
| Price to sales | 4.2 | 5.0 | 5.5 | 5.0 | 10.1 | 12.3 | 5.6 | 5.3 | 5.4 | 4.2 |
Dividends and splits
Per share, in the currency the company pays
Paid for 3 years. Last went ex-dividend on 1 Jul 2026.
| FY2026 | FY2025 | FY2024 | FY2023 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 1.01 | 1.42 | 1.82 | 1.18 | 1.225 | 1.165 | 1.02 | 0.835 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.